These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessing toxicant emissions from e-liquids with DIY additives used in response to a potential flavour ban in e-cigarettes. El-Hellani A; Soule EK; Daoud M; Salman R; El Hage R; Ardati O; El-Kaassamani M; Yassine A; Karaoghlanian N; Talih S; Saliba N; Shihadeh A Tob Control; 2022 Nov; 31(Suppl 3):s245-s248. PubMed ID: 36328456 [TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibitory activity in tobacco particulate matter: Are harman and norharman the only physiologically relevant inhibitors? Truman P; Grounds P; Brennan KA Neurotoxicology; 2017 Mar; 59():22-26. PubMed ID: 28057462 [TBL] [Abstract][Full Text] [Related]
4. Ethyl maltol, vanillin, corylone and other conventional confectionery-related flavour chemicals dominate in some e-cigarette liquids labelled 'tobacco' flavoured. Omaiye EE; Luo W; McWhirter KJ; Pankow JF; Talbot P Tob Control; 2022 Nov; 31(Suppl 3):s238-s244. PubMed ID: 36328460 [TBL] [Abstract][Full Text] [Related]
5. Impact of E-Cigarette Liquid Flavoring Agents on Activity of Microsomal Recombinant CYP2A6, the Primary Nicotine-Metabolizing Enzyme. Winters BR; Kochar TK; Clapp PW; Jaspers I; Madden MC Chem Res Toxicol; 2020 Jul; 33(7):1689-1697. PubMed ID: 32496054 [TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. Guillem K; Vouillac C; Azar MR; Parsons LH; Koob GF; Cador M; Stinus L J Neurosci; 2005 Sep; 25(38):8593-600. PubMed ID: 16177026 [TBL] [Abstract][Full Text] [Related]
7. A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke. Hong SW; Teesdale-Spittle P; Page R; Truman P Neurotoxicology; 2022 Dec; 93():163-172. PubMed ID: 36155069 [TBL] [Abstract][Full Text] [Related]
8. Comparison of monoamine oxidase inhibition by cigarettes and modified risk tobacco products. van der Toorn M; Koshibu K; Schlage WK; Majeed S; Pospisil P; Hoeng J; Peitsch MC Toxicol Rep; 2019; 6():1206-1215. PubMed ID: 31768332 [TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type. Lewis AJ; Truman P; Hosking MR; Miller JH Tob Control; 2012 Jan; 21(1):39-43. PubMed ID: 21636610 [TBL] [Abstract][Full Text] [Related]
10. Correlates of e-cigarette use before and after comprehensive regulatory changes and e-liquid flavour ban among general population. Ruokolainen O; Ollila H; Karjalainen K Drug Alcohol Rev; 2022 Jul; 41(5):1174-1183. PubMed ID: 35106874 [TBL] [Abstract][Full Text] [Related]
11. Effects of Common e-Liquid Flavorants and Added Nicotine on Toxicant Formation during Vaping Analyzed by Kerber PJ; Duell AK; Powers M; Strongin RM; Peyton DH Chem Res Toxicol; 2022 Jul; 35(7):1267-1276. PubMed ID: 35735356 [TBL] [Abstract][Full Text] [Related]
12. High Content Screening in NHBE cells shows significantly reduced biological activity of flavoured e-liquids, when compared to cigarette smoke condensate. Czekala L; Simms L; Stevenson M; Trelles-Sticken E; Walker P; Walele T Toxicol In Vitro; 2019 Aug; 58():86-96. PubMed ID: 30880017 [TBL] [Abstract][Full Text] [Related]
13. Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence. Prasopthum A; Pouyfung P; Sarapusit S; Srisook E; Rongnoparut P Drug Metab Pharmacokinet; 2015 Apr; 30(2):174-81. PubMed ID: 25857233 [TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. Khalil AA; Davies B; Castagnoli N Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520 [TBL] [Abstract][Full Text] [Related]
15. Effect of electronic cigarettes on human middle ear. Song JJ; Go YY; Mun JY; Lee S; Im GJ; Kim YY; Lee JH; Chang J Int J Pediatr Otorhinolaryngol; 2018 Jun; 109():67-71. PubMed ID: 29728187 [TBL] [Abstract][Full Text] [Related]
16. Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine. Smith TT; Rupprecht LE; Cwalina SN; Onimus MJ; Murphy SE; Donny EC; Sved AF Neuropsychopharmacology; 2016 Aug; 41(9):2335-43. PubMed ID: 26955970 [TBL] [Abstract][Full Text] [Related]
17. Investigation on the Antibacterial Activity of Electronic Cigarette Liquids (ECLs): A Proof of Concept Study. Fuochi V; Caruso M; Emma R; Stivala A; Polosa R; Distefano A; Furneri PM Curr Pharm Biotechnol; 2021; 22(7):983-994. PubMed ID: 32881666 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of Aldehyde Flavorant-Acetal Formation in E-Liquids with Different E-Cigarette Solvents and Common Additives Studied by Kerber PJ; Peyton DH Chem Res Toxicol; 2022 Aug; 35(8):1410-1417. PubMed ID: 35830545 [TBL] [Abstract][Full Text] [Related]